27 results on '"Obesity -- Drug therapy -- Risk factors"'
Search Results
2. Huge demand for new obesity drugs risks overwhelming NHS, Streeting told; More than 200 doctors and experts warn health secretary of 'enormous pressure' on already stretched services
3. Type 2 Diabetes Medications That Induce Weight Loss
4. Eli Lilly says its anti-obesity drug reduces diabetes risk by 94% in 3 years
5. EMA warns of risk of diabetes and obesity drugs prior to surgery with anesthesia
6. Risk of Suicidal Ideation Lower With Semaglutide vs Other Obesity, T2D Drugs
7. Risk of Suicidal Ideation Lower With Semaglutide vs Other Obesity, T2D Drugs
8. Case Western Reserve University School of Medicine Researcher Provides New Insights into Obesity and Diabetes (GLP-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data)
9. New Obesity and Diabetes Data Has Been Reported by a Researcher at University Hospital Aachen (Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction)
10. Reports from University of North Carolina Chapel Hill Advance Knowledge in Obesity (Metformin As a Therapeutic Agent for Obesity-associated Immune Dysfunction)
11. Washington University School of Medicine Researcher Provides New Data on Obesity and Diabetes (Novel Agents in the Management of Diabetes and Risk of Worsening Diabetic Retinopathy)
12. OptiMed adds Vida Health as a Preferred Partner, Introducing Innovative Anti-Obesity Medication Management Program
13. GLP-1RA MEDICATIONS FOR TYPE 2 DIABETES AND OBESITY MAY LOWER RISK OF ACUTE PANCREATITIS
14. Obesity Tied to Higher Risk of Breast Cancer Recurrence on Aromatase Inhibitors
15. Investigators at Charite University Hospital and School of Medicine Discuss Findings in Obesity (Early-set Pomc Methylation Variability Is Accompanied By Increased Risk for Obesity and Is Addressable By Mc4r Agonist Treatment)
16. The American Journal of Managed Care(R) (AJMC(R))'s Institute for Value-Based Medicine(R) (IVBM(R)) hosts event to highlight treatment options for obesity and minimizing risk of type 2 diabetes and cardiovascular disease
17. Wegovy(r) receives FDA approval for cardiovascular risk reduction in adults with known heart disease and overweight or obesity
18. Obesity drug Wegovy is approved to cut heart attack and stroke risk in overweight patients
19. Fighting obesity isn't as easy as taking drugs
20. SEMAGLUTIDE ASSOCIATED WITH LOWER RISK OF SUICIDAL IDEATIONS COMPARED TO OTHER TREATMENTS PRESCRIBED FOR OBESITY OR TYPE 2 DIABETES
21. Semaglutide associated with lower risk of suicidal ideations compared to other treatments prescribed for obesity or type 2 diabetes
22. Investigators from Philadelphia College of Osteopathic Medicine Target Obesity (tracheostomy Dislodgement: Are Obese Patients At Increased Risk?& Nbsp;)
23. New Clinical Data Demonstrate that QSYMIA(R), the Leading Once-Daily Oral Weight-Management Medication, Reduces Blood Pressure
24. Sefako Makgatho Health Sciences University Researcher Adds New Study Findings to Research in Hypertension (Uncontrolled Hypertension, Treatment, and Predictors among Hypertensive Out-Patients attending Primary Health Facilities in Johannesburg, ...)
25. European Interbalkan Medical Center Researcher Provides New Data on Obesity and Diabetes (Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug ...)
26. Reports from University of Arizona College of Medicine Highlight Recent Research in Obesity and Diabetes (Racial/ethnic minorities have greater declines in sleep duration with higher risk of cardiometabolic disease: An analysis of the U.S. ...)
27. Trial to investigate link between weight, fitness and cancer recurrence; Scientists to test hypothesis that a weight loss programme for breast cancer patients after medical treatment lowers risk of disease returning
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.